• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

University of Colorado; Public Coll/Univ - Unlimited Student Fees Jul 06

  • ID: 2031145
  • July 2006
  • Region: Colorado
  • Standard & Poors


  • University of Colorado
  • MORE

Standard & Poor's Ratings Services assigned its 'AA-' rating to the University of Colorado Board of Regents' $102.505 million enterprise refunding and improvement revenue bonds, series 2006A, issued for the University of Colorado (CU). Additionally, Standard & Poor's affirmed its 'AA-' and 'A+' ratings on CU's debt. The general credit strengths of CU include: Its position as Colorado's ('AA-/Stable' state certificates of participation rating) flagship university system; Broad revenue diversity, with low dependency on state appropriations and strong, expanding research activity; Solid student demand, with stabilizing enrollment; Balanced operating performance and good liquidity; and Capable central oversight of capital needs and funding sources. An offsetting credit factor is the uncertainty regarding the continued implementation of the College Opportunity Fund that...

Companies mentioned in this report are:
- University of Colorado

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown

- University of Colorado

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.